INS and colorectal carcinoma: Compared to the nOb-CRC group, the Ob-CRC group had significantly higher median levels of fasting plasma glucose (FPG, p < 0.01), fasting plasma insulin (FPI, p < 0.01) and the homeostasis model assessment of insulin resistance (HOMA-IR) values (p < 0.01).